Achieve Life Sciences Inc. (ACHV)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Propel Bio Management

Leen Kawas And Richard Kayne

2,453,092 $11,149,303 6.48%
2.
ADAR1 Capital Management

Daniel Schneeberger

875,000 $3,976,875 0.9%
3.
Altium Capital

Jacob Gottlieb

835,470 $3,797,211 1.5%
4.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

654,000 $2,972,430 0.16%
5. 471,000 $2,140,695 0.01%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.59 10,000 38,501 2024-03-04 Filing
$4.59 10,000 76,724 2024-03-04 Filing
$5.50 5,000 Officer, Director 66,730 2023-05-30 Filing
$0.00 22,000 Officer, Director 36,920 2022-11-18 Filing
$7.00 6,000 Officer, Director 6,141 2021-05-27 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.00 0 Large Shareholder 796,594 2019-06-11 Filing
$2.85 44,982 Large Shareholder 796,594 2019-06-11 Filing
$0.00 0 Large Shareholder 841,576 2019-06-11 Filing
$3.01 2,200 Large Shareholder 841,576 2019-06-11 Filing
$0.00 0 Large Shareholder 843,776 2019-06-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 725,000 $2,987,000 0.59%
2. 605,710 $2,495,525 0%
3. 248,099 $1,022,168 0.03%
4. 184,925 $762,095 0%
5. 178,500 $735,420 0%
News See All